Introducing a first in-depth look at OmniaBio’s facility in Hamilton, Ontario.

At 120,000 square feet, and visible from the highway that passes alongside McMaster Innovation Park in Hamilton, Ontario, OmniaBio Inc. is a beacon for cell and gene therapy companies. A subsidiary of CCRM, OmniaBio is built on a strong foundation established more than a decade ago. With the singular purpose of optimizing and manufacturing cells and viral vectors, OmniaBio is bringing maturity to the industry: it will be Canada’s largest contract manufacturer dedicated to cell and gene therapies.